Table II.
Mean Serum Sodium at Pre-dose and During Treatment, and Change from Pre-dose in Water-Loaded Subjects by Treatment Group
| Mean Serum Sodium (mmol/L) | Change from Pre-Dose (mmol/L) | |||||||
|---|---|---|---|---|---|---|---|---|
| AV002 Nasal Spray | SC | AV002 Nasal Spray | SC | |||||
| 0.5 μg (N = 12) |
1.0 μg (N = 12) |
2.0 μg (N = 12) |
0.12 μg (N = 6) |
0.5 μg (N = 12) |
1.0 μg (N = 12) |
2.0 μg (N = 12) |
0.12 μg (N = 6) |
|
| Pre-dose | 136.7 | 133.7 | 132.0 | 134.3 | − | − | − | − |
| 2 Hr. Post Dose | 134.2 | 130.2 | 131.4 | 130.7 | −2.5 | −3.5 | −0.6 | −3.6 |
| 4 Hr. Post Dose | 135.6 | 131.6 | 132.0 | 130.5 | −1.1 | −2.1 | 0 | −3.8 |
| 6 Hr. Post Dose | 137.5 | 134.5 | 132.0 | 132.3 | 0.8 | 0.8 | 0.8 | −2.0 |
| 8 Hr. Post Dose | 138.6 | 135.8 | 134.7 | 134.2 | 1.9 | 2.1 | 2.7 | −0.1 |
Hr hour, SC subcutaneous desmopressin injection